tradingkey.logo

IRadimed Corp

IRMD
97.060USD
+0.460+0.48%
收盘 12/24, 13:00美东报价延迟15分钟
1.23B总市值
58.23市盈率 TTM

IRadimed Corp

97.060
+0.460+0.48%

关于 IRadimed Corp 公司

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.

IRadimed Corp简介

公司代码IRMD
公司名称IRadimed Corp
上市日期Jul 16, 2014
CEOSusi (Roger)
员工数量160
证券类型Ordinary Share
年结日Jul 16
公司地址12705 Ingenuity Drive
城市ORLANDO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编32826
电话14076778022
网址https://www.iradimed.com/
公司代码IRMD
上市日期Jul 16, 2014
CEOSusi (Roger)

IRadimed Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
28.74K
-5.90%
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
28.16K
+239.42%
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.09K
+6.02%
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
5.98K
-0.25%
Jeffrey Chiprin
Jeffrey Chiprin
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Joe Kiani
Mr. Joe Kiani
Independent Director
Independent Director
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
28.74K
-5.90%
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
28.16K
+239.42%
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.09K
+6.02%
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
5.98K
-0.25%
Jeffrey Chiprin
Jeffrey Chiprin
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
MRI Compatible IV Infusion Pump Systems
8.19M
40.12%
MRI Compatible Patient Vital Signs Monitoring Systems
5.94M
29.13%
Disposables, services and other
5.20M
25.49%
Amortization of extended warranty agreements
592.45K
2.90%
Ferro Magnetic Detection Systems
482.20K
2.36%
地区USD
名称
营收
占比
United States
18.19M
89.13%
International
2.22M
10.87%
业务
地区
业务USD
名称
营收
占比
MRI Compatible IV Infusion Pump Systems
8.19M
40.12%
MRI Compatible Patient Vital Signs Monitoring Systems
5.94M
29.13%
Disposables, services and other
5.20M
25.49%
Amortization of extended warranty agreements
592.45K
2.90%
Ferro Magnetic Detection Systems
482.20K
2.36%

股东统计

更新时间: 11月14日 周五
更新时间: 11月14日 周五
持股股东
股东类型
持股股东
持股股东
占比
Susi (Roger E)
36.07%
Nine Ten Capital Management LLC
6.06%
BlackRock Institutional Trust Company, N.A.
5.26%
The Vanguard Group, Inc.
4.44%
Renaissance Technologies LLC
3.84%
其他
44.32%
持股股东
持股股东
占比
Susi (Roger E)
36.07%
Nine Ten Capital Management LLC
6.06%
BlackRock Institutional Trust Company, N.A.
5.26%
The Vanguard Group, Inc.
4.44%
Renaissance Technologies LLC
3.84%
其他
44.32%
股东类型
持股股东
占比
Individual Investor
36.79%
Investment Advisor/Hedge Fund
24.20%
Investment Advisor
21.09%
Hedge Fund
8.52%
Research Firm
2.03%
Pension Fund
1.50%
Bank and Trust
0.31%
Sovereign Wealth Fund
0.13%
Family Office
0.04%
其他
5.39%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
329
7.41M
58.27%
-960.52K
2025Q2
323
12.12M
95.27%
-1.02M
2025Q1
329
12.21M
96.19%
-859.52K
2024Q4
319
12.16M
95.93%
-668.30K
2024Q3
299
11.92M
94.09%
-356.11K
2024Q2
289
11.77M
92.95%
-163.43K
2024Q1
280
11.68M
92.20%
+22.27K
2023Q4
263
11.33M
89.87%
-741.29K
2023Q3
254
11.61M
92.13%
-662.68K
2023Q2
240
11.66M
92.58%
-250.35K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Susi (Roger E)
4.59M
36.07%
--
--
Apr 21, 2025
Nine Ten Capital Management LLC
872.00K
6.86%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
621.24K
4.88%
+12.94K
+2.13%
Jun 30, 2025
The Vanguard Group, Inc.
559.40K
4.4%
+6.58K
+1.19%
Jun 30, 2025
Renaissance Technologies LLC
491.81K
3.87%
-9.90K
-1.97%
Jun 30, 2025
Copeland Capital Management, LLC
457.92K
3.6%
-32.63K
-6.65%
Jun 30, 2025
Geode Capital Management, L.L.C.
261.39K
2.05%
+16.00K
+6.52%
Jun 30, 2025
BlackRock Financial Management, Inc.
260.47K
2.05%
-2.21K
-0.84%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
215.43K
1.69%
-4.75K
-2.16%
Jun 30, 2025
State Street Investment Management (US)
177.39K
1.39%
+1.71K
+0.97%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
AAM Sawgrass US Small Cap Quality Growth ETF
2.83%
Ballast Small/Mid Cap ETF
1.19%
Fundamentals First ETF
0.92%
State Street SPDR S&P Health Care Equipment ETF
0.47%
Royce Quant Small-Cap Quality Value ETF
0.4%
Lattice Hartford Multifactor Small Cap ETF
0.39%
ALPS Barron's 400 ETF
0.27%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.25%
WisdomTree US SmallCap Quality Dividend Growth
0.18%
WisdomTree U.S. SmallCap Dividend Fund
0.17%
查看更多
AAM Sawgrass US Small Cap Quality Growth ETF
占比2.83%
Ballast Small/Mid Cap ETF
占比1.19%
Fundamentals First ETF
占比0.92%
State Street SPDR S&P Health Care Equipment ETF
占比0.47%
Royce Quant Small-Cap Quality Value ETF
占比0.4%
Lattice Hartford Multifactor Small Cap ETF
占比0.39%
ALPS Barron's 400 ETF
占比0.27%
SPDR SSGA US Small Cap Low Volatility Index ETF
占比0.25%
WisdomTree US SmallCap Quality Dividend Growth
占比0.18%
WisdomTree U.S. SmallCap Dividend Fund
占比0.17%

分红派息

近5年累计派现 39.46M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 13, 2025
IRMD.NB Interim Cash Dividend of gross USD 0.17 paid on Mar 05, 2025 going ex on Feb 24, 2025
Feb 24, 2025
Mar 05, 2025
Feb 24, 2025
Oct 31, 2024
IRMD.NB Final Cash Dividend of gross USD 0.15 paid on Nov 25, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 25, 2024
Nov 15, 2024
Aug 01, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on Aug 30, 2024 going ex on Aug 20, 2024
Aug 20, 2024
Aug 30, 2024
Aug 20, 2024
May 02, 2024
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on May 30, 2024 going ex on May 17, 2024
May 20, 2024
May 30, 2024
May 17, 2024
Dec 12, 2023
IRMD.NB Interim Cash Dividend of gross USD 0.15 paid on Jan 12, 2024 going ex on Dec 21, 2023
Dec 22, 2023
Jan 12, 2024
Dec 21, 2023

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

IRadimed Corp的前五大股东是谁?

IRadimed Corp 的前五大股东如下:
Susi (Roger E)持有股份:4.59M,占总股份比例:36.07%。
Nine Ten Capital Management LLC持有股份:872.00K,占总股份比例:6.86%。
BlackRock Institutional Trust Company, N.A.持有股份:621.24K,占总股份比例:4.88%。
The Vanguard Group, Inc.持有股份:559.40K,占总股份比例:4.40%。
Renaissance Technologies LLC持有股份:491.81K,占总股份比例:3.87%。

IRadimed Corp的前三大股东类型是什么?

IRadimed Corp 的前三大股东类型分别是:
Susi (Roger E)
Nine Ten Capital Management LLC
BlackRock Institutional Trust Company, N.A.

有多少机构持有IRadimed Corp(IRMD)的股份?

截至2025Q3,共有329家机构持有IRadimed Corp的股份,合计持有的股份价值约为7.41M,占公司总股份的58.27%。与2025Q2相比,机构持股有所增加,增幅为-37.01%。

哪个业务部门对IRadimed Corp的收入贡献最大?

在FY2025Q2,MRI Compatible IV Infusion Pump Systems业务部门对IRadimed Corp的收入贡献最大,创收8.19M,占总收入的40.12%。
KeyAI